Dr. Lei Zhu, Walter Reed Army Institute of Research, Clinical Trials Center, research coordinator prepare samples prior to the RV575 research study, Sept. 27, 2022. In October, the U.S. Military HIV Research Program will launch the phase 1 study, evaluating varying doses of the Army's novel ALFQ adjuvant in a candidate HIV vaccine to determine the optimal adjuvant dosage level. (U.S. Army photo by Mike Walters/ Released)
| Date Taken: | 09.27.2022 |
| Date Posted: | 10.05.2022 18:38 |
| Photo ID: | 7450977 |
| VIRIN: | 220927-A-PR201-0004 |
| Resolution: | 8192x5464 |
| Size: | 15.44 MB |
| Location: | SILVER SPRING, MARYLAND, US |
| Web Views: | 54 |
| Downloads: | 13 |
This work, U.S. Military HIV Research Program launches RV575 HIV research study [Image 10 of 10], by Mike Walters, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
No keywords found.
